(Q51369597)
Statements
Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus (English)
J W Stephens
T B Bodvarsdottir
K Wareham
S L Prior
R M Bracken
G D Lowe
A Rumley
10 August 2011